Related Experiment Video
Updated: Jan 16, 2026
06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
16.8K
HDAC2 promotes malignant progression by the RBM47/NONO axis in medulloblastoma
Houji Song1, Siyu Zhang1, Jie Chen1
1Cancer Center, Medical Research Institute, State Key Laboratory of Resource Insects, Southwest University, Chongqing 400716, China.
Translational Oncology
|September 30, 2025
Summary
Histone deacetylase 2 (HDAC2) drives pediatric medulloblastoma (MB) growth by modulating oncogene expression. Inhibiting HDAC2 suppressed tumor progression and increased sensitivity to chemotherapy, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Medulloblastoma (MB) is a common pediatric brain tumor, accounting for 20% of childhood brain malignancies.
- Histone acetylation modifications are crucial for tumor development, but their role in MB is understudied.
- Histone deacetylase 2 (HDAC2) is implicated in modulating oncogene expression and promoting tumorigenesis in MB.
Purpose of the Study:
- To investigate the biological functions and underlying mechanisms of HDAC2 in medulloblastoma.
- To evaluate the therapeutic potential of targeting the HDAC2 pathway in MB.
Main Methods:
- Lentivirus-mediated RNA interference (RNAi) was used to deplete HDAC2 in MB cells.
- Cell proliferation, migration, and invasion were assessed using EdU, flow cytometry, and Transwell assays.
- Mechanisms were explored via qRT-PCR, Western blot, CHIP-qPCR, and Luciferase reporter assays in cell line-derived xenograft (CDX) models.
Main Results:
- HDAC2 was found to be overexpressed in MB patient tissues and cell lines.
- HDAC2 depletion significantly inhibited MB cell proliferation, migration, and invasion.
- HDAC2 promotes RBM47 expression via H3K27 deacetylation, leading to increased NONO expression and enhanced temozolomide sensitivity.
Conclusions:
- HDAC2 plays a significant oncogenic role in medulloblastoma.
- The HDAC2/RBM47/NONO signaling axis represents a potential therapeutic target for MB treatment.
- Targeting HDAC2 may improve treatment efficacy for medulloblastoma patients.
Related Concept Videos
01:20The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
02:38The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K